Xylose Lysine Deoxycholate (XLD) Agar Supply

The contract is for the supply of Xylose Lysine Deoxycholate Agar, a selective growth medium used for isolating Salmonella and Shigella species from clinical samples, supporting diagnostic efforts in public health and clinical laboratories. The agreement is structured as a subcontract under the U.S. Embassy in Tbilisi, Department of State, with performance centered in Tbilisi, Georgia, and a zip code of 0186. The North American Industry Classification System code 424690 indicates it relates to medical and dental equipment and supplies merchant wholesalers, pointing to the commercial nature of the procurement. The contract was posted on July 10, 2026, and while no solicitation number or set-aside details are provided, it reflects a targeted procurement to ensure consistent access to critical diagnostic media for pathogen detection. The absence of a designated point of contact suggests a streamlined administrative process, and the placement of performance in Tbilisi indicates the supplies are intended for use by local health authorities, laboratories, or medical facilities operating under U.S. diplomatic public health support initiatives. The specificity of the agar type underscores the need for standardized, reliable laboratory reagents in pathogen surveillance and outbreak response.